Status:

COMPLETED

Treatment of Patients With Active Neurocysticercosis in Eastern Africa

Lead Sponsor:

Technical University of Munich

Collaborating Sponsors:

National Institute for Medical Research, Tanzania

University of Zambia

Conditions:

Neurocysticercosis

Eligibility:

All Genders

10+ years

Brief Summary

This multi-centre prospective cohort study of symptomatic patients with active neurocysticercosis (NCC) aims to identify factors related to treatment success of anthelmintic therapy. Neurological sym...

Eligibility Criteria

Inclusion

  • All patients will be included who
  • Meet the definitions of active NCC
  • Have epilepsy, epileptic seizures or chronic/severe progressive headaches
  • Are physically and mentally fit enough for treatment
  • Are willing to be hospitalized and to receive the standard treatment for NCC
  • Are willing to participate a follow-up for six months
  • Are willing and able to consent to this study, with consent recorded on a signed consent form

Exclusion

  • Potential participants who will not meet the above inclusion criteria will be excluded.
  • Women who are pregnant will not be included, but re-evaluated for inclusion into the study after they have given birth.
  • Potential participants who are currently taking or have taken albendazole, praziquantel, or a corticosteroid within the past 12 months will be excluded.
  • People with uncontrolled hypertension and/or diabetes will be excluded from the study but will be re-evaluated for inclusion once their hypertension and/or diabetes have been treated.
  • People with chronic consuming illness such as cancer and those with mental handicap severe enough to not allow them to follow the study instructions or reliably take their medication will be excluded.
  • Children aged \<10 years.

Key Trial Info

Start Date :

April 1 2019

Trial Type :

OBSERVATIONAL

Allocation :

ACTUAL

End Date :

January 31 2022

Estimated Enrollment :

63 Patients enrolled

Trial Details

Trial ID

NCT03834337

Start Date

April 1 2019

End Date

January 31 2022

Last Update

November 30 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

National Institute of Medical Research

Dar es Salaam, Tanzania